These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23833124)

  • 21. Mammography surveillance and mortality in older breast cancer survivors.
    Lash TL; Fox MP; Buist DS; Wei F; Field TS; Frost FJ; Geiger AM; Quinn VP; Yood MU; Silliman RA
    J Clin Oncol; 2007 Jul; 25(21):3001-6. PubMed ID: 17548838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival differences among women with de novo stage IV and relapsed breast cancer.
    Dawood S; Broglio K; Ensor J; Hortobagyi GN; Giordano SH
    Ann Oncol; 2010 Nov; 21(11):2169-2174. PubMed ID: 20427349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.
    Monsees GM; Malone KE; Tang MT; Newcomb PA; Li CI
    J Natl Cancer Inst; 2011 Dec; 103(23):1752-60. PubMed ID: 22021667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.
    Guha N; Kwan ML; Quesenberry CP; Weltzien EK; Castillo AL; Caan BJ
    Breast Cancer Res Treat; 2009 Nov; 118(2):395-405. PubMed ID: 19221874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.
    Gierach GL; Curtis RE; Pfeiffer RM; Mullooly M; Ntowe EA; Hoover RN; Nyante SJ; Feigelson HS; Glass AG; Berrington de Gonzalez A
    JAMA Oncol; 2017 Feb; 3(2):186-193. PubMed ID: 27711920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cardiac death after adjuvant radiotherapy for breast cancer.
    Giordano SH; Kuo YF; Freeman JL; Buchholz TA; Hortobagyi GN; Goodwin JS
    J Natl Cancer Inst; 2005 Mar; 97(6):419-24. PubMed ID: 15770005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
    Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
    JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
    Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
    J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
    Calip GS; Yu O; Elmore JG; Boudreau DM
    Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of women with a personal history of breast cancer by tumour subtype.
    Benveniste AP; Dryden MJ; Bedrosian I; Morrow PK; Bassett RL; Yang W
    Clin Radiol; 2017 Mar; 72(3):266.e1-266.e6. PubMed ID: 28341031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer.
    Caan BJ; Kwan ML; Hartzell G; Castillo A; Slattery ML; Sternfeld B; Weltzien E
    Cancer Causes Control; 2008 Dec; 19(10):1319-28. PubMed ID: 18752034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
    Kato I; Booza J; Quarshie WO; Schwartz K
    J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.
    Calip GS; Elmore JG; Boudreau DM
    Breast Cancer Res Treat; 2017 Jan; 161(1):161-172. PubMed ID: 27826756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
    Izano M; Satariano WA; Hiatt RA; Braithwaite D
    Cancer Med; 2015 Feb; 4(2):315-24. PubMed ID: 25511535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothyroidism and the risk of breast cancer recurrence and all-cause mortality - a Danish population-based study.
    Falstie-Jensen AM; Kjærsgaard A; Lorenzen EL; Jensen JD; Reinertsen KV; Dekkers OM; Ewertz M; Cronin-Fenton DP
    Breast Cancer Res; 2019 Mar; 21(1):44. PubMed ID: 30902106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular medication use and risks of colon cancer recurrences and additional cancer events: a cohort study.
    Bowles EJA; Yu O; Ziebell R; Chen L; Boudreau DM; Ritzwoller DP; Hubbard RA; Boggs JM; Burnett-Hartman AN; Sterrett A; Fujii M; Chubak J
    BMC Cancer; 2019 Mar; 19(1):270. PubMed ID: 30917783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis.
    Nechuta S; Chen WY; Cai H; Poole EM; Kwan ML; Flatt SW; Patterson RE; Pierce JP; Caan BJ; Ou Shu X
    Int J Cancer; 2016 May; 138(9):2088-97. PubMed ID: 26606746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of breast cancer in relation to antibiotic use.
    Tamim HM; Hanley JA; Hajeer AH; Boivin JF; Collet JP
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):144-50. PubMed ID: 17943999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.
    Greenlee H; Kwan ML; Kushi LH; Song J; Castillo A; Weltzien E; Quesenberry CP; Caan BJ
    Cancer; 2012 Apr; 118(8):2048-58. PubMed ID: 21953120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study.
    Nottage MK; Kopciuk KA; Tzontcheva A; Andrulis IL; Bull SB; Blackstein ME
    Breast Cancer Res; 2006; 8(4):R44. PubMed ID: 16859523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.